MCHP: Time to Buy Puts on Microchip Technology?

AI-powered insights updated on 11/4/2025.

AI Signal: Strongly Bearish outlook with confirming negative momentum.
Microchip Technology (MCHP) exhibits a bearish setup due to declining sales, margin compression, and negative technical indicators. Traders should consider put options to capitalize on the expected downside.

Trend Strength

Below 50-day Moving Average

R S I Momentum

Weakening momentum

30- Day Change

Underperforming industry average

MCHP Earnings Date & Key Events

Key upcoming dates for MCHP that could impact its stock price.
DateEventType
11/6/2025MCHP Earnings
MCHP-Specific

Full Analysis Breakdown

About

Microchip Technology develops, manufactures, and sells embedded control solutions, including general-purpose and specialized mixed-signal microcontrollers, microprocessors, analog, FPGA, and memory products. Their 'Total System Solution' (TSS) combines hardware, software, and services. Target markets include automotive, aerospace and defense, communications, consumer appliances, data centers and computing, and industrial sectors. The company differentiates itself by offering a broad product portfolio, including 8-bit, 16-bit, 32-bit, and recently, 64-bit architectures, alongside analog and FPGA solutions. Microchip focuses on providing cost-effective solutions with small size, high performance, low power usage, and ease of development, utilizing a network of direct sales personnel and distributors to reach a diverse customer base.

News Summary

No relevant news was found for this stock today.

Technicals

MCHP's technical outlook is bearish. The stock price has experienced a significant decline over the past 90 days, falling from approximately $70 to the current price of $59.50. The price is below its 21-day EMA of $64.11 and its 50-day SMA of $64.87, confirming the downtrend. The MACD is negative and trending further downward, with the MACD line at -0.709 and the signal line at -0.399, indicating increasing bearish momentum. The RSI is at 42.92, suggesting the stock is not yet oversold but is approaching that level. The stochastic oscillator shows the %K line at 9.41 and the %D line at 16.70, indicating oversold conditions in the short term, but this is unlikely to reverse the overall bearish trend. The ADX is at 16.25, suggesting the downtrend is not particularly strong, but it is still trending downwards. Recent price action confirms the bearish trend, with the most recent close near the low of the day. Therefore, the trend is expected to continue downwards over the next 1-3 months.

Management Discussion

The MD&A reveals a challenging period for the company. `Net sales` for the three months ended June 30, 2025, decreased by 13.4% to $1,075.5 million compared to $1,241.3 million in the same period of the prior year, which management attributes primarily to customers reducing orders due to high inventory levels and, 'to a lesser extent, adverse economic conditions'. The `Gross Profit` margin also declined significantly, from 59.4% to 53.6%, driven by unfavorable sales volume, product mix, geographic mix, and unabsorbed capacity charges. The company's `Net cash provided by operating activities` for the three months ended June 30, 2025 was $275.6 million. Inventory levels decreased to $1.17 billion at June 30, 2025, from $1.29 billion at March 31, 2025, reflecting efforts to manage production and demand. Capital expenditures were reduced to $17.9 million in the current quarter, signaling a pause in factory expansion. Management anticipates that gross margins will fluctuate over time, driven primarily by capacity utilization levels, the overall mix of products sold during the period, as well as manufacturing yields, unabsorbed capacity charges, and competitive and economic conditions in the markets served. Overall, the report paints a picture of a company navigating a downturn, with reduced sales, lower margins, and cautious capital spending.

Earnings Call

Microchip's Q1 Fiscal 2026 earnings call reflects a moderately bullish outlook. The company reported a strong sequential sales growth of 10.8%, exceeding the high end of their updated June quarter guidance, driven by what CEO Steve Sanghi termed a 'trifecta effect' of inventory correction at distributors and direct customers. Management anticipates this positive dynamic to continue, projecting net sales for the September quarter to be $1.13 billion, plus or minus $20 million, representing above-seasonal growth. Non-GAAP gross margin is expected to be between 55% and 57% of sales, and non-GAAP diluted earnings per share between $0.30 and $0.36. While automotive is lagging compared to other end markets, the company saw recovery across all product lines and geographies. Lead times are extending, prompting management to advise customers to maintain 12 to 16 weeks of backlog. CFO Eric Bjornholt noted that distribution sell-through was '$49.3 million higher than distribution sell-in,' indicating continued inventory depletion in the channel. Overall, management's tone is optimistic, emphasizing the leverage in their business model and the potential for accelerated gross margin recovery.

Financials

MCHP's financial performance reveals a concerning trend. Revenue has decreased significantly from a high of $2,254.3M in Q2 2024 to $1,075.5M in Q1 2026, indicating a substantial downturn in sales. Profitability, as measured by the grossProfitRatio, has also declined from 0.678 to 0.536 over the same period, suggesting increased cost pressures or reduced pricing power. While the company generated positive operating cash flow of $275.6M in the latest quarter, this follows a period of fluctuating cash flow. The company's solvency position shows a concerning pattern, with total debt decreasing from $6,108.1M in Q2 2024 to $5,494.5M in Q1 2026. The negative net income of -$18.6M in the most recent quarter further underscores the challenges MCHP faces. These factors collectively raise concerns about MCHP's financial health and its trajectory over the next 6-12 months.

Fundamentals

The company presents a moderately bullish investment profile based on its key metrics and financial ratios. Revenue has shown positive growth, indicating a healthy demand for its products or services. The gross margin has remained relatively stable, suggesting efficient cost management. The Return on Equity (ROE) indicates a solid return for shareholders. The Price-to-Earnings (P/E) ratio suggests the company is appropriately valued by the market. The debt-to-equity ratio has seen a decrease, showcasing the company's improved financial leverage. The current ratio signifies the company's strong ability to meet its short-term obligations. Overall, the company demonstrates a stable and growing business model with a healthy balance sheet, making it a moderately attractive investment for the next 6-12 months.

Unlock Data-Driven Options Setups
Go beyond static reports with an interactive dashboard
Access daily, top-rated Call & Put setups
Track performance for every signal we issue
Start Your Free 30-Day Trial
Disclaimer

The information provided on this page is for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other sort of advice and you should not treat any of the page's content as such. ProfitScout does not recommend that any security should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions.

Related Stocks

    We Use Cookies

    We use cookies to enhance your experience, analyze site traffic, and for marketing purposes. By clicking "Accept," you agree to our use of cookies. Read our Privacy Policy.